Recombinant porcine FVIII for bleed treatment in acquired hemophilia A: findings from a single-center, 18-patient cohort
Author:
Affiliation:
1. Division of Hematology-Oncology, Department of Medicine,
2. Division of Pediatric Hematology-Oncology, Department of Pediatrics, and
3. Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC
Abstract
Publisher
American Society of Hematology
Subject
Hematology
Link
http://ashpublications.org/bloodadvances/article-pdf/4/24/6240/1795334/advancesadv2020002977.pdf
Reference30 articles.
1. Acquired hemophilia A: Updated review of evidence and treatment guidance;Kruse-Jarres;Am J Hematol,2017
2. Acquired hemophilia: a case report and review of the literature;Mulliez;Int J Lab Hematol,2014
3. Acquired factor VIII inhibitors: pathophysiology and treatment;Ma;Hematology Am Soc Hematol Educ Program,2006
4. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2);Knoebl;J Thromb Haemost,2012
5. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A;Huth-Kühne;Haematologica,2009
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Agreement between one stage and chromogenic assays in samples from patients receiving recombinant porcine FVIII (Obizur, Susoctocog‐alfa);International Journal of Laboratory Hematology;2023-10-05
2. Real‐world safety and effectiveness of recombinant porcine sequence factor VIII in acquired haemophilia A: A non‐interventional, post‐authorization safety study;Haemophilia;2023-08-16
3. Surgery and Prophylaxis with Susoctocog-Alfa in Acquired Hemophilia: Case Series and Literature Review;Journal of Clinical Medicine;2023-07-10
4. Emicizumab for acquired haemophilia A: A case series;Haemophilia;2023-06-05
5. Evaluating the financial impact of utilizing recombinant porcine factor VIII or recombinant FVIIa for patients with acquired hemophilia A;Expert Review of Pharmacoeconomics & Outcomes Research;2023-01-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3